Gene · 10076
Papers2,589
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,589
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Study on SHP2 Conformational Transition and Structural Characterization of Its High-Potency Allosteric Inhibitors by Molecular Dynamics Simulations Combined with Machine Learning. | Molecules | 2024 | 39795072 | PubTator, text mining | PubMed |
| Identification of Diagnostic and Prognostic Subnetwork Biomarkers for Women with Breast Cancer Using Integrative Genomic and Network-Based Analysis. | Int J Mol Sci | 2024 | 39684488 | PubTator, text mining | PubMed |
| Investigating the Effect of Blurring and Focusing Current in Cochlear Implant Users with the Panoramic ECAP Method. | J Assoc Res Otolaryngol | 2024 | 39414747 | PubTator, text mining | PubMed |
| Multipartite Fluorogenic Sensors for Monitoring Tyrosine Phosphatase Activity. | Chembiochem | 2024 | 39406683 | PubTator, text mining | PubMed |
| Protein Biomarkers of Ultra-Processed Food Consumption and Risk of Coronary Heart Disease, Chronic Kidney Disease, and All-Cause Mortality. | J Nutr | 2024 | 39299474 | PubTator, text mining | PubMed |
| Body composition trajectories during childhood predict skeletal maturation at puberty: A longitudinal study. | Heliyon | 2024 | 39253277 | PubTator, text mining | PubMed |
| Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases. | Acta Pharm Sin B | 2024 | 39220870 | PubTator, text mining | PubMed |
| [Characteristic Analysis of Adult Acute Myeloid Leukemia Patients with PTPN11 Gene Mutation]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39192399 | PubTator, text mining | PubMed |
| Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases. | Drug Resist Updat | 2024 | 39094301 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of Pyrido[1,2-a]pyrimidin-4-one derivatives as novel allosteric SHP2 inhibitors. | Bioorg Chem | 2024 | 39067422 | PubTator, text mining | PubMed |
| From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond. | Pharmaceutics | 2024 | 39065585 | PubTator, text mining | PubMed |
| Anti-Adenoviral Effect of Human Argonaute 2 Alone and in Combination with Artificial microRNAs. | Cells | 2024 | 38994969 | PubTator, text mining | PubMed |
| Contact sensitization to fragrance mix I and fragrance mix II among European dermatitis patients: A systematic review. | Contact Dermatitis | 2024 | 38945918 | PubTator, text mining | PubMed |
| Efficient simulation of Time-Fractional Korteweg-de Vries equation via conformable-Caputo non-Polynomial spline method. | PLoS One | 2024 | 38923964 | PubTator, text mining | PubMed |
| Protein tyrosine phosphatases: emerging role in cancer therapy resistance. | Cancer Commun (Lond) | 2024 | 38741380 | PubTator, text mining | PubMed |
| Probing the Immunoreceptor Tyrosine-Based Inhibition Motif Interaction Protein Partners with Proteomics. | Molecules | 2024 | 38731468 | PubTator, text mining | PubMed |
| Leveraging machine learning models for peptide-protein interaction prediction. | RSC Chem Biol | 2024 | 38725911 | PubTator, text mining | PubMed |
| Immunotherapeutic implications of negative regulation by protein tyrosine phosphatases in T cells: the emerging cases of PTP1B and TCPTP. | Front Med (Lausanne) | 2024 | 38707187 | PubTator, text mining | PubMed |
| SHP2 regulates GluA2 tyrosine phosphorylation required for AMPA receptor endocytosis and mGluR-LTD. | Proc Natl Acad Sci U S A | 2024 | 38657042 | PubTator, text mining | PubMed |
| Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer. | Int J Mol Sci | 2024 | 38612874 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10076/papers?page=6